HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 160 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $949,000 | +59.5% | 110,000 | +75.2% | 0.91% | +50.6% |
| Q1 2016 | $595,000 | -82.1% | 62,800 | -73.0% | 0.60% | -82.1% |
| Q1 2015 | $3,317,000 | +411.1% | 232,300 | +245.2% | 3.37% | +426.2% |
| Q4 2014 | $649,000 | +50.9% | 67,300 | +42.3% | 0.64% | +90.2% |
| Q3 2014 | $430,000 | -83.1% | 47,300 | -81.6% | 0.34% | -81.6% |
| Q2 2014 | $2,539,000 | -43.0% | 257,000 | -26.7% | 1.83% | -51.1% |
| Q1 2014 | $4,453,000 | -13.1% | 350,500 | +2.5% | 3.74% | -9.6% |
| Q4 2013 | $5,127,000 | – | 342,000 | – | 4.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |